347 related articles for article (PubMed ID: 30421111)
1. Efficient production of porcine circovirus virus-like particles using the nonconventional yeast Kluyveromyces marxianus.
Duan J; Yang D; Chen L; Yu Y; Zhou J; Lu H
Appl Microbiol Biotechnol; 2019 Jan; 103(2):833-842. PubMed ID: 30421111
[TBL] [Abstract][Full Text] [Related]
2. Efficient expression and purification of porcine circovirus type 2 virus-like particles in Escherichia coli.
Wu PC; Chen TY; Chi JN; Chien MS; Huang C
J Biotechnol; 2016 Feb; 220():78-85. PubMed ID: 26795354
[TBL] [Abstract][Full Text] [Related]
3. Purification and characterization of immunogenic recombinant virus-like particles of porcine circovirus type 2 expressed in silkworm pupae.
Masuda A; Lee JM; Miyata T; Sato T; Hayashi S; Hino M; Morokuma D; Karasaki N; Mon H; Kusakabe T
J Gen Virol; 2018 Jul; 99(7):917-926. PubMed ID: 29851377
[TBL] [Abstract][Full Text] [Related]
4. Reduction of Postweaning Multisystemic Wasting Syndrome-Associated Clinical Symptoms by Virus-Like Particle Vaccine Against Porcine Parvovirus and Porcine Circovirus Type 2.
Liu G; Qiao X; Chang C; Hua T; Wang J; Tang B; Zhang D
Viral Immunol; 2020; 33(6):444-456. PubMed ID: 32255758
[TBL] [Abstract][Full Text] [Related]
5. Structure-Based Design of Porcine Circovirus Type 2 Chimeric VLPs (cVLPs) Displays Foreign Peptides on the Capsid Surface.
Wang D; Zhang S; Zou Y; Yu W; Jiang Y; Zhan Y; Wang N; Dong Y; Yang Y
Front Cell Infect Microbiol; 2018; 8():232. PubMed ID: 30038901
[TBL] [Abstract][Full Text] [Related]
6. Characterization of porcine circovirus type 2 (PCV2) capsid particle assembly and its application to virus-like particle vaccine development.
Wu PC; Lin WL; Wu CM; Chi JN; Chien MS; Huang C
Appl Microbiol Biotechnol; 2012 Sep; 95(6):1501-7. PubMed ID: 22526782
[TBL] [Abstract][Full Text] [Related]
7. Optimized production of full-length PCV2d virus-like particles in Escherichia coli: A cost-effective and high-yield approach for potential vaccine antigen development.
Zhang C; He F; Li N; Du W; Wen J; Wu X; Shi J; Li C; Liu C; Xu S; Han H; Hrabchenko N; Han X; Li J
Microb Pathog; 2024 May; 190():106630. PubMed ID: 38556102
[TBL] [Abstract][Full Text] [Related]
8. A novel subunit vaccine co-expressing GM-CSF and PCV2b Cap protein enhances protective immunity against porcine circovirus type 2 in piglets.
Zhang H; Qian P; Peng B; Shi L; Chen H; Li X
Vaccine; 2015 May; 33(21):2449-56. PubMed ID: 25863115
[TBL] [Abstract][Full Text] [Related]
9. Preparation of virus-like particles for porcine circovirus type 2 by YeastFab Assembly.
Chen P; Zhang L; Chang N; Shi P; Gao T; Zhang L; Huang J
Virus Genes; 2018 Apr; 54(2):246-255. PubMed ID: 29417333
[TBL] [Abstract][Full Text] [Related]
10. The Carboxyl Terminus of the Porcine Circovirus Type 2 Capsid Protein Is Critical to Virus-Like Particle Assembly, Cell Entry, and Propagation.
Zhan Y; Yu W; Cai X; Lei X; Lei H; Wang A; Sun Y; Wang N; Deng Z; Yang Y
J Virol; 2020 Apr; 94(9):. PubMed ID: 32075927
[TBL] [Abstract][Full Text] [Related]
11. Generation in yeast of recombinant virus-like particles of porcine circovirus type 2 capsid protein and their use for a serologic assay and development of monoclonal antibodies.
Nainys J; Lasickiene R; Petraityte-Burneikiene R; Dabrisius J; Lelesius R; Sereika V; Zvirbliene A; Sasnauskas K; Gedvilaite A
BMC Biotechnol; 2014 Dec; 14():100. PubMed ID: 25487652
[TBL] [Abstract][Full Text] [Related]
12. The optimized capsid gene of porcine circovirus type 2 expressed in yeast forms virus-like particles and elicits antibody responses in mice fed with recombinant yeast extracts.
Bucarey SA; Noriega J; Reyes P; Tapia C; Sáenz L; Zuñiga A; Tobar JA
Vaccine; 2009 Sep; 27(42):5781-90. PubMed ID: 19664739
[TBL] [Abstract][Full Text] [Related]
13. Generation and immunogenicity assessment of ELPylated virus-like particles of porcine circovirus type 2.
Li Y; Wang Y; Cheng J; Zhou X; Lu H; Zhang X; Xia X; Sun H
Virol J; 2020 Jun; 17(1):72. PubMed ID: 32517704
[TBL] [Abstract][Full Text] [Related]
14. Generation and immunogenicity of porcine circovirus type 2 chimeric virus-like particles displaying porcine reproductive and respiratory syndrome virus GP5 epitope B.
Hu G; Wang N; Yu W; Wang Z; Zou Y; Zhang Y; Wang A; Deng Z; Yang Y
Vaccine; 2016 Apr; 34(16):1896-903. PubMed ID: 26930366
[TBL] [Abstract][Full Text] [Related]
15. Efficient application of a baculovirus-silkworm larvae expression system for obtaining porcine circovirus type 2 virus-like particles for a vaccine.
He Q; Cao Z; Wang P; Lu Q; Zheng H; Sun J
Arch Virol; 2020 Oct; 165(10):2301-2309. PubMed ID: 32757056
[TBL] [Abstract][Full Text] [Related]
16. Incorporation of a truncated form of flagellin (TFlg) into porcine circovirus type 2 virus-like particles enhances immune responses in mice.
Liu X; Liu Y; Zhang Y; Zhang F; Du E
BMC Vet Res; 2020 Feb; 16(1):45. PubMed ID: 32028949
[TBL] [Abstract][Full Text] [Related]
17. Comparison of immune effects of porcine circovirus type 2d (PCV2d) capsid protein expressed by Escherichia coli and baculovirus-insect cells.
Wang Y; Xu F; Yuan C; Zhang Y; Ren J; Yue H; Ma T; Song Q
Vaccine; 2024 Apr; 42(11):2848-2857. PubMed ID: 38514351
[TBL] [Abstract][Full Text] [Related]
18. Comparison of Immune Responses to the PCV2 Replicase-Capsid and Capsid Virus-Like Particle Vaccines in Mice.
Jung BK; Kim HR; Lee YH; Jang H; Chang KS
J Microbiol Biotechnol; 2019 Mar; 29(3):482-488. PubMed ID: 30609882
[TBL] [Abstract][Full Text] [Related]
19. Generation of E. coli-derived virus-like particles of porcine circovirus type 2 and their use in an indirect IgG enzyme-linked immunosorbent assay.
Zhang Y; Wang Z; Zhan Y; Gong Q; Yu W; Deng Z; Wang A; Yang Y; Wang N
Arch Virol; 2016 Jun; 161(6):1485-91. PubMed ID: 26973229
[TBL] [Abstract][Full Text] [Related]
20. Structural roles of PCV2 capsid protein N-terminus in PCV2 particle assembly and identification of PCV2 type-specific neutralizing epitope.
Mo X; Li X; Yin B; Deng J; Tian K; Yuan A
PLoS Pathog; 2019 Mar; 15(3):e1007562. PubMed ID: 30822338
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
